Recent progress in broadly neutralizing antibodies to HIV
- 17 October 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Immunology
- Vol. 19 (11), 1179-1188
- https://doi.org/10.1038/s41590-018-0235-7
Abstract
In this Review, we highlight some recent developments in the discovery and application of broadly neutralizing antibodies (bnAbs) to human immunodeficiency virus (HIV); i.e., antibodies able to neutralize diverse isolates of HIV. We consider the characterization of novel bnAbs, recent data on the effects of bnAbs in vivo in humans and animal models, and the importance of both kinds of data for the application of Abs to prophylaxis and therapy and to guide vaccine design. We seek to place newly discovered bnAbs in the context of existing bnAbs, and we explore the various characteristics of the antibodies that are most desirable for different applications.Keywords
This publication has 109 references indexed in Scilit:
- HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known EpitopesJournal of Virology, 2018
- Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infectionScience Translational Medicine, 2017
- Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cowsNature, 2017
- Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor RepertoiresCell, 2016
- Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibodyScience, 2016
- Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin MiceCell, 2015
- Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope TrimersImmunity, 2014
- Human Peripheral Blood Antibodies with Long HCDR3s Are Established Primarily at Original Recombination Using a Limited Subset of Germline GenesPLOS ONE, 2012
- Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected IndividualsPLOS ONE, 2010
- Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal AntibodyScience, 1994